Key result
Treating isolated subsegmental PE without DVT lacks trial consensus, requiring case-by-case clinical decisions.
Why the study?
The clinical significance of subsegmental pulmonary embolism and isolated subsegmental pulmonary embolism remains unclear, with limited data to guide appropriate management and anticoagulation decisions.
Should anticoagulation be used in patients with isolated subsegmental pulmonary embolism?
Should anticoagulation be used in patients with isolated subsegmental pulmonary embolism?
This review highlights the ongoing clinical dilemma and lack of definitive evidence regarding the necessity of anticoagulation for isolated subsegmental pulmonary embolism.
Uncertainty persists for anticoagulation in isolated subsegmental PE without DVT; leaves open the need for dedicated RCTs to guide practice.
The advent of computed tomography pulmonary angiography allowed better visualization of peripheral vessels, thereby increasing rates of subsegmental pulmonary embolism (SSPE), but there are minimal changes in mortality. The true clinical significance of SSPE and isolated SSPE (ISSPE) remains unclear. Patients with small pulmonary embolism (PE) usually present with chest pain or no symptoms, frequently classified as having a low clinical probability of PE. Those with central embolism, on the other hand, present dyspnea as the most common symptom. It is possible that ISSPE could represent a subset of a more benign disease and be not clinically relevant among patients with PE. There is a therapeutic dilemma in patients with small PE: should anticoagulation be used or not in all cases? As there are limited data to guide the appropriate management of ISSPE, this short review addresses the controversy over the therapeutic challenges in SSPE and ISSPE.
No takes yet. Share an insight, caveat, or question.
Yoo et al. (2020) conducted a review in Isolated subsegmental pulmonary embolism (ISSPE). Anticoagulation vs. Clinical surveillance / No anticoagulation was evaluated. There is no consistent consensus from randomized controlled trials on whether to treat patients with isolated subsegmental pulmonary embolism without deep vein thrombosis, and case-by-case decision making is recommended.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: